Another phase of Novartis Animal Vaccines, Inc.'s purchase of ImmTech Biologics and Grand Laboratories is complete. (Marketing News).

Another phase of Novartis Novartis International AG (NYSE: NVS) is a multinational pharmaceutical company based in Basel, Switzerland that manufactures drugs such as diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Animal Vaccines, Inc.'s purchase of ImmTech Biologics and Grand Laboratories is complete. ImmTech Biologics of Bucyrus, Kan., is now operating and is known as Novartis Animal Vaccines, Inc. The research and manufacturing facility at Bucyrus, Kan., will serve as a Novartis production site. This production site will continue its research and development focus, providing veterinarians Veterinarians and veterinary surgeons (vets) are medical professionals who operate exclusively on animals. Well-known and notable veterinarians include:

Wayne Allard, a U.S.

and producers with custom vaccines that meet specific and immediate needs, as well as such commercial products as FUSOGARD[R] and Treponema Treponema /Trep·o·ne·ma/ (trep?o-ne´mah) a genus of bacteria (family Spirochaetaceae), often pathogenic and parasitic; it includes the etiologic agents of pinta(T. cara´teum), syphilis(T. Bacterin bac·ter·in
n.
A suspension of killed or weakened bacteria used as a vaccine.

bacterin

vaccine consisting of killed bacteria. .

COPYRIGHT 2002 Doane Information Service
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Comment:	Another phase of Novartis Animal Vaccines, Inc.'s purchase of ImmTech Biologics and Grand Laboratories is complete. (Marketing News).
Publication:	Agri Marketing
Article Type:	Brief Article
Geographic Code:	1USA
Date:	Sep 1, 2002
Words:	83
Previous Article:	JC Robinson Seeds. (Marketing People).
Next Article:	CHS Marketing, LLC, a company formed by the owners of Curry Seed, Hoegemeyer Hybrids and Bo-Jac Seed, has reached an agreement with Dow AgroSciences,...
Topics:	Drugs Pharmaceutical industry Product development

Related Articles
Vaccine, pharmaceutical products, and bioterrorism: challenges for the US Food and Drug Administration.
Novartis Animal Vaccines. (Marketing People).
Answering your questions about disease prevention and food quality. (Talking quality).
U.S. acquisitions give European vaccine maker a shot in the arm.